Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients

Breast Cancer Research and Treatment

Volumn 126, Issue 1, 2011, Pages 1-14

  Nagai, Maria Aparecida ^a   Gerhard, Renê ^a   Fregnani, José Humberto T G ^b   Nonogaki, Suely ^c   Rierger, Regina Barbosa ^a   Netto, Mário Mourão ^d   Soares, Fernando A ^d  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b BARRETOS CANCER HOSPITAL   (Brazil)

^c INSTITUTO ADOLFO LUTZ   (Brazil)

^d A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Breast cancer; Immunohistochemistry; NDRG1; Protein expression; SPARC; Tissue microarray

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; N MYC DOWN REGULATED GENE 1; ONCOPROTEIN; OSTEONECTIN; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TISSUE MICROARRAY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CELL CYCLE PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; OSTEONECTIN; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79151471367     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0867-2     Document Type: Article

References (51)

1. C López-Otín EP Diamandis 1998 Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical features Endocr Rev 19 4 365 396 10.1210/er.19.4.365 9715372 (Pubitemid 29116015)
2. A Jemal R Siegel E Ward Y Hao J Xu T Murray MJ Thun 2008 Cancer statistics CA Cancer J Clin 58 71 96 10.3322/CA.2007.0010 18287387 (Pubitemid 351521864)
3. INCA (Instituto Nacional Do Câncer)-Ministério Da Saúde. Estimativas da Incidência e Mortalidade por Câncer no Brasil. http://www.inca.gov.br
4. T Vargo-Gogola JM Rosen 2007 Modelling breast cancer: one size does not fit all Nat Rev Cancer 7 9 659 672 1:CAS:528:DC%2BD2sXpsFSjsbw%3D 10.1038/nrc2193 17721431 (Pubitemid 47327411)
5. CM Perou T Sørlie MB Eisen M van de Rijn SS Jeffrey CA Rees JR Pollack DT Ross H Johnsen LA Akslen O Fluge A Pergamenschikov C Williams SX Zhu PE Lønning AL Børresen-Dale PO Brown D Botstein 2000 Molecular portraits of human breast tumours Nature 406 6797 747 752 1:CAS:528: DC%2BD3cXmt1CnsLw%3D 10.1038/35021093 10963602
6. S Bandyopadhyay SK Pai S Hirota S Hosobe Y Takano K Saito D Piquemal T Commes M Watabe S Gross Y Wang S Ran K Watabe 2004 Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression Oncogene 23 5675 5681 1:CAS:528:DC%2BD2cXlvVehs7Y%3D 10.1038/sj.onc.1207734 15184886 (Pubitemid 39093045)
7. G Watkins A Douglas-Jones R Bryce RE Mansel WG Jiang 2005 Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes Prostaglandins Leukot Essent Fatty Acids 72 4 267 272 1:CAS:528:DC%2BD2MXitFeqsb8%3D 10.1016/j.plefa.2004.12.003 15763438 (Pubitemid 40342998)
8. R Leth-Larsen R Lund HV Hansen AV Laenkholm D Tarin ON Jensen HJ Ditzel 2009 Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry Mol Cell Proteomics 8 6 1436 1449 1:CAS:528:DC%2BD1MXhtVegurnI 10.1074/mcp.M800061-MCP200 19321434
9. A Bergamaschi E Tagliabue T Sørlie B Naume T Triulzi R Orlandi HG Russnes JM Nesland R Tammi P Auvinen VM Kosma S Ménard AL Børresen-Dale 2008 Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome J Pathol 214 3 357 367 1:CAS:528:DC%2BD1cXivVSgt7c%3D 10.1002/path.2278 18044827 (Pubitemid 351212391)
10. Y Maruyama M Ono A Kawahara T Yokoyama Y Basaki M Kage S Aoyagi H Kinoshita M Kuwano 2006 Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis Cancer Res 66 12 6233 6242 1:CAS:528:DC%2BD28XlvVSkt7s%3D 10.1158/0008-5472.CAN-06-0183 16778198
11. S Stein EK Thomas B Herzog MD Westfall JV Rocheleau RS Jackson 2nd M Wang P Liang 2004 NDRG1 is necessary for p53-dependent apoptosis J Biol Chem 279 47 48930 48940 1:CAS:528:DC%2BD2cXpslKjsLg%3D 10.1074/jbc.M400386200 15377670 (Pubitemid 39625774)
12. A Chlenski S Liu LJ Guerrero Q Yang Y Tian HR Salwen P Zage SL Cohn 2006 SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix Int J Cancer 118 2 310 316 1:CAS:528:DC%2BD2MXhtlWqs7fK 10.1002/ijc.21357 16052522 (Pubitemid 41779069)
13. PA Puolakkainen RA Brekken S Muneer EH Sage 2004 Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis Mol Cancer Res 2 4 215 224 1:CAS:528:DC%2BD2cXjvVKnur0%3D 15140943 (Pubitemid 39031082)
14. ML dos Santos CG Palanch S Salaorni WA Da Silva MA Nagai Jr 2006 Transcriptome characterization of human mammary cell lines expressing different levels of ERBB2 by serial analysis of gene expression Int J Oncol 28 6 1441 1461 16685446
15. P Lachat P Shaw S Gebhard N van Belzen P Chaubert FT Bosman 2002 Expression of NDRG1, a differentiation-related gene, in human tissues Histochem Cell Biol 118 399 408 1:CAS:528:DC%2BD38Xos1eltLk%3D 10.1007/s00418-002-0460-9 12432451 (Pubitemid 35352125)
16. N van Belzen WNM Dinjens MPG Diesveld NA Groen ACJ van der Made Y Nozawa R Vliestra J Trapman FT Bosman 1997 A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms Lab Invest 77 85 92 9251681 (Pubitemid 27328362)
17. RJ Guan HL Ford Y Fu Y Li LM Shaw AB Pardee 2000 Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer Cancer Res 60 3 749 755 1:CAS:528:DC%2BD3cXht1Gmur0%3D 10676663 (Pubitemid 30094577)
18. A Nishie K Masuda M Otsubo T Migita M Tsuneyoshi K Kohno T Shuin S Naito M Ono M Kuwano 2001 High expression of the Cap43 gene in infiltrating macrophages of human renal cell carcinomas Clin Cancer Res 7 7 2145 2151 1:CAS:528:DC%2BD3MXlslaksro%3D 11448934 (Pubitemid 32994855)
19. H Cangul 2004 Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers BMC Genet 5 27 37 10.1186/1471-2156-5-27 15341671 (Pubitemid 41363876)
20. JT Chang HM Wang KW Chang WH Chen MC Wen YM Hsu BY Yung IH Chen CT Liao LL Hsieh AJ Cheng 2005 Identification of differentially expressed genes in oral squamous cell carcinoma (OSCC): overexpression of NPM, CDK1 and NDRG1 and underexpression of CHES1 Int J Cancer 114 6 942 949 1:CAS:528: DC%2BD2MXjsFWjsrs%3D 10.1002/ijc.20663 15645429 (Pubitemid 40504475)
21. RP Caruso B Levinson J Melamed R Wieczorek S Taneja D Polsky C Chang A Zeleniuch-Jacquotte K Salnikow H Yee M Costa I Osman 2004 Altered N-myc downstream-regulated gene 1 protein expression in African-American compared with caucasian prostate cancer patients Clin Cancer Res 10 222 227 1:CAS:528:DC%2BD2cXkvF2mtA%3D%3D 10.1158/1078-0432.CCR-0604-3 14734473 (Pubitemid 38114183)
22. MS Chua H Sun ST Cheung V Mason J Higgins DT Ross ST Fan S So 2007 Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma Mod Pathol 20 1 76 83 1:CAS:528:DC%2BD28XhtlaktrnK 10.1038/modpathol.3800711 17170744 (Pubitemid 44967952)
23. M Fukunaga-Kalabis M Herlyn 2007 Unraveling mysteries of the multifunctional protein SPARC J Invest Dermatol 127 11 2497 2498 1:CAS:528:DC%2BD2sXhtFKisbvF 10.1038/sj.jid.5701050 17934501 (Pubitemid 47585075)
24. OL Podhajcer L Benedetti MR Girotti F Prada E Salvatierra AS Llera 2008 The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host Cancer Metastasis Rev 27 3 523 537 1:CAS:528: DC%2BD1cXovFyitLY%3D 10.1007/s10555-008-9135-x 18459035
25. C Jones A Mackay A Grigoriadis A Cossu JS Reis-Filho L Fulford T Dexter S Davies K Bulmer E Ford S Parry M Budroni G Palmieri AM Neville MJ O'Hare SR Lakhani 2004 Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer Cancer Res 64 9 3037 3045 1:CAS:528:DC%2BD2cXjs1ehsbk%3D 10.1158/0008-5472.CAN-03-2028 15126339 (Pubitemid 38581402)
26. AH Beck I Espinosa CB Gilks M van de Rijn RB West 2008 The fibromatosis signature defines a robust stromal response in breast carcinoma Lab Invest 88 6 591 601 1:CAS:528:DC%2BD1cXmt1Sgt7s%3D 10.1038/labinvest.2008.31 18414401 (Pubitemid 351733278)
27. PA Netti DA Berk MA Swartz AJ Grodzinsky RK Jain 2000 Role of extracellular matrix assembly in interstitial transport in solid tumors Cancer Res 60 9 2497 2503 1:CAS:528:DC%2BD3cXjtV2qtLo%3D 10811131
28. SY Sung CL Hsieh D Wu LW Chung PA Johnstone 2007 Tumor microenvironment promotes cancer progression, metastasis, and therapeutic resistance Curr Probl Cancer 31 2 36 100 10.1016/j.currproblcancer.2006.12.002 17362788 (Pubitemid 46386278)
29. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of NCI-EORTC Working Group on Cancer Diagnostics (2006) Reporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat 100(2):229-235
30. AJ Norton S Jordan P Yeomans 1994 Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues J Pathol 173 371 379 1:STN:280:DyaK2M%2FlsVOnsA%3D%3D 10.1002/path.1711730413 7965396 (Pubitemid 24294106)
31. DC Allred JM Harvey M Berardo GM Clark 1998 Prognostic and predictive factors in breast cancer by immunohistochemical analysis Mod Pathol 11 2 155 168 1:STN:280:DyaK1c7mtlaitg%3D%3D 9504686 (Pubitemid 28144151)
32. TO Nielsen FD Hsu K Jensen M Cheang G Karaca Z Hu T Hernandez-Boussard C Livasy D Cowan L Dressler LA Akslen J Ragaz AM Gown CB Gilks M van de Rijn CM Perou 2004 Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 16 5367 5374 1:CAS:528:DC%2BD2cXmvFSlt7k%3D 10.1158/1078-0432.CCR-04-0220 15328174 (Pubitemid 39100473)
33. LK Diaz R Gupta N Kidwai N Sneige EL Wiley 2004 The use of TMA for interlaboratory validation of FISH testing for detection of HER2 gene amplification in breast cancer J Histochem Cytochem 52 4 501 507 1:CAS:528:DC%2BD2cXjtVaqt7o%3D 15034001 (Pubitemid 38420384)
34. B Strzelczyk A Szulc R Rzepko A Kitowska J Skokowski A Szutowicz T Pawelczyk 2009 Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion Ann Surg Oncol 16 5 1287 1294 10.1245/s10434-009-0381-0 19259744
35. A Fotovati T Fujii M Yamaguchi M Kage K Shirouzu S Oie Y Basaki M Ono H Yamana M Kuwano 2006 17Beta-estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells Clin Cancer Res 12 10 3010 3018 1:CAS:528:DC%2BD28Xks1CitrY%3D 10.1158/1078-0432.CCR-05-1962 16707596 (Pubitemid 43837345)
36. RA Brekken EH Sage 2001 SPARC, a matricellular protein: at the crossroads of cell-matrix communication Matrix Biol 19 8 816 827 1:STN:280: DC%2BD3Mzit1ygug%3D%3D 10.1016/S0945-053X(00)00133-5 11223341 (Pubitemid 32153838)
37. SA Arnold RA Brekken 2009 SPARC: a matricellular regulator of tumorigenesis J Cell Commun Signal 3 3-4 255 273 10.1007/s12079-009-0072-4 19809893
38. SA Rempel WA Golembieski S Ge N Lemke K Elisevich T Mikkelsen JA Gutiérrez 1998 SPARC: a signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas J Neuropathol Exp Neurol 57 12 1112 1121 1:CAS:528:DyaK1MXhs1Cqsg%3D%3D 10.1097/00005072- 199812000-00002 9862633 (Pubitemid 28562739)
39. G Rumpler B Becker C Hafner M McClelland W Stolz M Landthaler R Schmitt A Bosserhoff T Vogt 2003 Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypes Exp Dermatol 12 6 761 771 1:CAS:528:DC%2BD2cXmslOlug%3D%3D 10.1111/j.0906-6705.2003.00082.x 14714555 (Pubitemid 38028667)
40. SJ Dawson E Provenzano C Caldas 2009 Triple negative breast cancers: clinical and prognostic implications Eur J Cancer 1 27 40 10.1016/S0959-8049(09) 70013-9
41. PJ Barth R Moll A Ramaswamy 2005 Stromal remodeling and SPARC (secreted protein acid rich in cysteine) expression in invasive ductal carcinomas of the breast Virchows Arch 446 5 532 536 1:CAS:528:DC%2BD2MXksl2gsrc%3D 10.1007/s00428-005-1256-9 15838642 (Pubitemid 40884287)
42. D Sarrió SM Rodriguez-Pinilla D Hardisson A Cano G Moreno-Bueno J Palacios 2008 Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype Cancer Res 68 4 989 997 10.1158/0008-5472.CAN-07-2017 18281472 (Pubitemid 351272216)
43. J Helleman MP Jansen K Ruigrok-Ritstier IL van Staveren MP Look ME Meijer-van Gelder AM Sieuwerts JG Klijn S Sleijfer JA Foekens EM Berns 2008 Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response Clin Cancer Res 14 17 5555 5564 1:CAS:528:DC%2BD1cXhtVKmsbbK 10.1158/1078-0432.CCR-08-0555 18765548
44. SY Wong D Crowley RT Bronson RO Hynes 2008 Analyses of the role of endogenous SPARC in mouse models of prostate and breast cancer Clin Exp Metastasis 25 2 109 118 1:CAS:528:DC%2BD1cXmtFyhtbo%3D 10.1007/s10585-007-9126-2 18058030
45. MJ Socha N Said Y Dai J Kwong P Ramalingam V Trieu N Desai SC Mok K Motamed 2009 Aberrant promoter methylation of SPARC in ovarian cancer Neoplasia 11 2 126 135 1:CAS:528:DC%2BD1MXhvVOls7o%3D 19177197
46. IT Tai M Dai DA Owen LB Chen 2005 Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy J Clin Invest 115 6 1492 1502 1:CAS:528:DC%2BD2MXkvF2mu7w%3D 10.1172/JCI23002 15902309 (Pubitemid 40814658)
47. S Cheetham MJ Tang F Mesak H Kennecke D Owen IT Tai 2008 SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response Br J Cancer 98 11 1810 1819 1:CAS:528:DC%2BD1cXmtlCis7o%3D 10.1038/sj.bjc.6604377 18458674 (Pubitemid 351748842)
48. N Dhanesuan JA Sharp T Blick JT Price EW Thompson 2002 Doxycycline-inducible expression of SPARC/Osteonectin/BM40 in MDA-MB-231 human breast cancer cells results in growth inhibition Breast Cancer Res Treat 75 1 73 85 1:CAS:528:DC%2BD38Xls1Cmsr0%3D 10.1023/A:1016536725958 12500936
49. CK Yunker W Golembieski N Lemke CR Schultz S Cazacu C Brodie SA Rempel 2008 SPARC-induced increase in glioma matrix and decrease in vascularity are associated with reduced VEGF expression and secretion Int J Cancer 122 12 2735 2743 1:CAS:528:DC%2BD1cXht1eku7rP 10.1002/ijc.23450 18350569 (Pubitemid 351631375)
50. GK Yiu WY Chan SW Ng PS Chan KK Cheung RS Berkowitz SC Mok 2001 SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells Am J Pathol 159 2 609 622 1:CAS:528:DC%2BD3MXms1WitrY%3D 11485919
51. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 1 57 70 1:CAS:528:DC%2BD3cXks1CktA%3D%3D 10.1016/S0092-8674(00)81683-9 10647931 (Pubitemid 30046295)